192 related articles for article (PubMed ID: 16301574)
1. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
[TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Rutteman GR; Gärtner Mde F
APMIS; 2007 Apr; 115(4):327-34. PubMed ID: 17504299
[TBL] [Abstract][Full Text] [Related]
4. Expression of beta-catenin, E-cadherin and APC in canine mammary tumors.
Restucci B; Maiolino P; Martano M; Esposito G; De Filippis D; Borzacchiello G; Lo Muzio L
Anticancer Res; 2007; 27(5A):3083-9. PubMed ID: 17970048
[TBL] [Abstract][Full Text] [Related]
5. The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands.
Zhang ZY; Wu YQ; Zhang WG; Tian Z; Cao J
Chin J Dent Res; 2000 Nov; 3(3):36-9. PubMed ID: 11314533
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours.
Zappulli V; De Cecco S; Trez D; Caliari D; Aresu L; Castagnaro M
J Comp Pathol; 2012; 147(2-3):161-70. PubMed ID: 22520821
[TBL] [Abstract][Full Text] [Related]
8. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
9. [Expressions and significance of E-cadherin and beta-catenin in synovial sarcoma].
Sun BC; Sun Y; Zhao XL; Liu YX; Zhang SW; Liu YX
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):727-30. PubMed ID: 16483482
[TBL] [Abstract][Full Text] [Related]
10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin and β-catenin expression in canine colorectal adenocarcinoma.
Aresu L; Pregel P; Zanetti R; Caliari D; Biolatti B; Castagnaro M
Res Vet Sci; 2010 Dec; 89(3):409-14. PubMed ID: 20457460
[TBL] [Abstract][Full Text] [Related]
12. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y
Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890
[TBL] [Abstract][Full Text] [Related]
13. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma.
Saito T; Oda Y; Sakamoto A; Tamiya S; Kinukawa N; Hayashi K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2000 Nov; 192(3):342-50. PubMed ID: 11054718
[TBL] [Abstract][Full Text] [Related]
15. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs.
Alves Pereira KM; do Amaral BA; dos Santos BR; Galvão HC; Freitas Rde A; de Souza LB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):425-31. PubMed ID: 20219600
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin and alpha-catenin expression in human esophageal cancer.
Kadowaki T; Shiozaki H; Inoue M; Tamura S; Oka H; Doki Y; Iihara K; Matsui S; Iwazawa T; Nagafuchi A
Cancer Res; 1994 Jan; 54(1):291-6. PubMed ID: 8261454
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin immunoreactivity in canine mammary tumors.
Sarli G; Preziosi R; De Tolla L; Brunetti B; Benazzi C
J Vet Diagn Invest; 2004 Nov; 16(6):542-7. PubMed ID: 15586569
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
Demirkan NC; Bir F; Erdem O; Düzcan E
J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]